Semaglutide can be transformative for weight loss, but using the right dose matters
Reports have shown a lower incidence of anxiety and depression in GLP-1 analog users [like semaglutide] compared with nonusers, possibly due to anti-inflammatory effects on neuroinflammation and reduced concern about weight gain, says Roshani Sanghani, MD, an endocrinologist in private practice who sees patients via telemedicine
This would dampen any possibility of weight loss drugs changing consumer behaviour in the long term
What the discount ask would cost If public plans cover Mounjaro, CDA estimates it could cost them $1.97 billion over three years about $820 million more than the plans currently spend on comparable drugs over a similar period [Source: theglobeandmail.com/business/economy/article-canada-drug-agency-mounjaro-recommendation-type-2-diabetes/]
Personal triumphs showcase the profound impact of semaglutide on individuals' lives, highlighting its potential to revolutionize the treatment landscape
In obese subjects, supraphysiological dose of GLP-1 reduces appetite and food intake, which subsequently induces weight loss, alleviates GLP-1 resistance, and increases insulin sensitivity 43
